Literature DB >> 18509244

Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients.

Tomoko Sakata1, Ryuichi Furuya, Takako Shimazu, Mari Odamaki, Sakae Ohkawa, Hiromichi Kumagai.   

Abstract

BACKGROUND: Increased oxidative stress is associated with various complications in hemodialysis (HD) patients.
METHODS: We examined the effect of coenzyme Q10 (CoQ10) administration on the plasma oxidative products and antioxidant capacity in 36 HD patients for 6 months.
RESULTS: The advanced oxidation protein products (AOPP), malondialdehyde and the percentage of ubiquinone in total CoQ10 were significantly higher in HD patients than in healthy subjects before administration (0 month). Oxygen radical absorbing capacity (ORAC) and Trolox equivalent antioxidant capacity (TEAC), indicators of total antioxidant capacity, were also paradoxically higher in the HD patients at 0 month. AOPP and the percentage of ubiquinone significantly decreased during CoQ10 administration, but increased again after the discontinuation. ORAC and TEAC were also decreased during CoQ10 administration.
CONCLUSION: The CoQ10 administration was partially effective for suppressing the oxidative stress in HD patients. The unexpected decrease of ORAC and TEAC by CoQ10 seemed to be associated with a decreased oxidative stress. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509244     DOI: 10.1159/000135605

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  11 in total

1.  A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease.

Authors:  Yongxing Xu; Guolei Yang; Xiaowen Zuo; Jianjun Gao; Huaping Jia; Enhong Han; Juan Liu; Yan Wang; Hong Yan
Journal:  Int Urol Nephrol       Date:  2021-03-29       Impact factor: 2.370

2.  Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.

Authors:  Jonathan Himmelfarb; T Alp Ikizler; Charles Ellis; Pingsheng Wu; Ayumi Shintani; Sanjay Dalal; Mark Kaplan; Michel Chonchol; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 10.121

3.  Influence of adjuvant Coenzyme Q10 on inflammatory and oxidative stress biomarkers in patients with bipolar disorders during the depressive episode.

Authors:  Leila Jahangard; Fatemeh Yasrebifar; Mohammad Haghighi; Akram Ranjbar; Maryam Mehrpooya
Journal:  Mol Biol Rep       Date:  2019-07-25       Impact factor: 2.316

4.  Role of alpha-lipoic acid in the management of anemia in patients with chronic renal failure undergoing hemodialysis.

Authors:  Gehad A El-Nakib; Tarek M Mostafa; Tarek M Abbas; Mamdouh M El-Shishtawy; Mokhtar M Mabrouk; Mohammed A Sobh
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-08-27

Review 5.  Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Int J Mol Sci       Date:  2014-11-05       Impact factor: 5.923

6.  A review on the role of quinones in renal disorders.

Authors:  Jennifer Madeo; Adeel Zubair; Frieri Marianne
Journal:  Springerplus       Date:  2013-04-01

7.  Effect of coenzyme-q10 on Doxorubicin-induced nephrotoxicity in rats.

Authors:  Azza A K El-Sheikh; Mohamed A Morsy; Marwa M Mahmoud; Rehab A Rifaai; Aly M Abdelrahman
Journal:  Adv Pharmacol Sci       Date:  2012-12-17

8.  Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress.

Authors:  Catherine K Yeung; Frederic T Billings; Adam J Claessens; Baback Roshanravan; Lori Linke; Mary B Sundell; Suhail Ahmad; Baohai Shao; Danny D Shen; T Alp Ikizler; Jonathan Himmelfarb
Journal:  BMC Nephrol       Date:  2015-11-03       Impact factor: 2.388

Review 9.  Mitochondria: a new therapeutic target in chronic kidney disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Paola Tomei; Antonio Lupo; Gianluigi Zaza
Journal:  Nutr Metab (Lond)       Date:  2015-11-25       Impact factor: 4.169

Review 10.  Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review.

Authors:  Konstantina P Poulianiti; Antonia Kaltsatou; Georgia I Mitrou; Athanasios Z Jamurtas; Yiannis Koutedakis; Maria Maridaki; Ioannis Stefanidis; Giorgos K Sakkas; Christina Karatzaferi
Journal:  Oxid Med Cell Longev       Date:  2016-08-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.